Berkoz Mehmet
Department of Biochemistry, Faculty of Pharmacy, Van Yuzuncu Yil University, 65080, Van, Turkey.
Gen Physiol Biophys. 2019 Jul;38(4):315-324. doi: 10.4149/gpb_2019010. Epub 2019 Jun 26.
Diosmin is an unsaturated flavonoid glycoside, presents in citrus fruits. The aim of this study is to investigate the molecular mechanism of diosmin with respect to the NF-κB and MAPKs signaling pathways. Firstly, 10, 20, 30, 40 and 50 µM diosmin were treated to lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages. The anti-inflammatory effects of diosmin was displayed via measuring prostaglandin E2 (PGE2), nitric oxide (NO), interleukines (IL-6, IL-12), tumor necrosis factor α (TNF-α) production, cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), IL-6, IL-12, TNF-α mRNA levels, and phosphorylation levels of nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor alpha (IκB-α) and mitogen-activated protein kinases (MAPKs); JNK, ERK, and p38 in LPS induced RAW264.7 macrophages. Our study showed that especially high concentrations of diosmin decreased NO, PGE2, IL-6, IL-12, TNF-α production and mRNA levels of these mediators (p < 0.05). The expression of phosphorylated-JNK was significantly suppressed by diosmin at 40 and 50 µM concentrations. Furthermore, diosmin significantly inhibited the expression of phosphorylated-ERK, p38, and p-IκB-α in a dose-dependent manner. Our results suggest that diosmin is a potent anti-inflammatory agent and has potential for development into a therapeutic agent for inflammation-associated disorders.
地奥司明是一种不饱和黄酮糖苷,存在于柑橘类水果中。本研究的目的是探讨地奥司明在核因子κB(NF-κB)和丝裂原活化蛋白激酶(MAPKs)信号通路方面的分子机制。首先,将10、20、30、40和50μM的地奥司明作用于脂多糖(LPS)刺激的RAW264.7巨噬细胞。通过测量前列腺素E2(PGE2)、一氧化氮(NO)、白细胞介素(IL-6、IL-12)、肿瘤坏死因子α(TNF-α)的产生、环氧合酶-2(COX-2)、诱导型一氧化氮合酶(iNOS)、IL-6、IL-12、TNF-α的mRNA水平,以及B细胞中κ轻链多肽基因增强子的核因子抑制剂α(IκB-α)和丝裂原活化蛋白激酶(MAPKs);JNK、ERK和p38在LPS诱导的RAW264.7巨噬细胞中的磷酸化水平,来显示地奥司明的抗炎作用。我们的研究表明,尤其是高浓度的地奥司明可降低NO、PGE2、IL-6、IL-12、TNF-α的产生以及这些介质的mRNA水平(p<0.05)。40和50μM浓度的地奥司明显著抑制磷酸化-JNK的表达。此外,地奥司明以剂量依赖性方式显著抑制磷酸化-ERK、p38和p-IκB-α的表达。我们的结果表明,地奥司明是一种有效的抗炎剂,具有开发成炎症相关疾病治疗药物的潜力。